-
Dividends by Country
Australia
Canada
Germany
Japan
Hong Kong
Netherlands
United Kingdom
United States
-
Dividends by Index
BOVESPA
DAX 30
FTSE 100
Nasdaq
NYSE
S&P/ASX 50
S&P/TSX 60
Straits Times
3 Undervalued UK ADRs Trading On The NYSE
Published Wed, 24 Feb 2016 20:45 CET by DividendYields.org
The London Stock Exchange offers value investors great stocks with strong fundamentals and a sustained dividend growth. However, with the currency exchange rates, it is often expensive for US investors to invest directly in the LSE. Through the ADRs - in this article American Depositary Receipts -, value investors can invest in foreign stocks that trade in the NYSE or the Nasdaq at the lowest cost.Another thing to consider is whether a stock is over- or undervalued. This means that its market price is higher or lower than its present value. When a stock is overvalued and its market price is higher than its present value, investors should sell the stock as it is already more expensive than its actual value and it is highly unlikely to rise further. When a stock is undervalued and its market price is lower than its present value, investors should buy the stock as it is expected that it will rise further.
There are several methods to assess if a stock is over- or undervalued, the most popular being the Graham Number and the Dividend Discount Model (DDM). However, the Graham Number doesn’t take into consideration the dividend growth or other fundamentals of the company and thereby, it is not effective for mid and large-caps.
In this article we discuss three British ADRs, large caps of different sectors that trade on the NYSE. According to the Dividend Discount Model, all three are undervalued.

British American Tobacco (ADR) (NYSE: BTI) is a London-based tobacco manufacturer and seller that provides cigarettes, cigars, and a range of nicotine products, and electronic cigarettes worldwide. British American Tobacco operates under Benson & Hedges, Craven A., Dunhill, John Player Gold Leaf, Kent, Kool, Lucky Strike, Pall Mall, Peter Stuyvesant, Rothmans, State Express 555, Viceroy and Vogue brand names and sells its products in Europe, Asia-Pacific, the Americas, Africa and the Middle East.
Strong Fundamentals: British American Tobacco is a financially healthy company with strong fundamentals. In its Q3 2015 results, the company’s revenues grew 4.2% YoY without adjusting for currency fluctuation, mainly driven by sustained strong pricing and growth in low price segments. The revenue growth has led to an increase in cigarette market share by 40 basis points in primary growth regions like Australia, France, Indonesia, Japan, Malaysia, Pakistan, Russia, South Korea, Turkey, Ukraine and the UK.
Dividend Growth: British American Tobacco declares an annualized dividend of $3.09, yielding 2.81% at a payout ratio of 50%. Since 2000, the company has been consistently delivering a dividend, reaching a 146.5% dividend growth, or 9.8% annually. Considering a discount rate of 28%, the present value of the stock is $109.92 / (0.28 - 0.10) = $109.92 / 0.18 = $610.67. Since the present value is significantly higher than the market price, the stock is seen as undervalued.
The ADR enables investors to buy British American Tobacco stock at a price that is significantly cheaper than the trading price on the London Stock Exchange (LSE). Through the ADR, value investors can invest in a fundamentally strong company at a lower cost.
GlaxoSmithKline (ADR) (NYSE: GSK) is a Brentford-based developer, manufacturer, and seller of pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. GlaxoSmithKline provides pharmaceutical products, consumer healthcare products in wellness, oral health, nutrition, and skin health areas and has collaboration agreements with Université de Sherbrooke and Pfizer; development and R&D collaboration with Propeller Health; R&D collaboration agreement with Valneva SE; and collaboration and license agreement with Idera pharmaceuticals.
Strong Fundamentals: In FY 2015 results, GlaxoSmithKline reported revenues $23.9 billion, down 9.5% YoY from $26.4 billion in FY 2014. On the upside, operating expenses were down 33.3% YoY, operating income was up 52.9% YoY and net income reached $8.4 billion, up 87.2% from 4.5 billion in the same period last year. In spite of the debt-to-equity ratio of 3.0, which is normal for a drug company since the pharmaceutical sector is highly capital-intensive, GlaxoSmithKline is a financially healthy company and a great pick for value investors.
Dividend Growth: GlaxoSmithKline declares an annualized dividend of $2.60, yielding 6.74% at a payout ratio of 54%. The company’s dividend growth since 2000 is 33.5% or 2.2% annually. Considering a discount rate of 25%, the present value of the stock is $39.76 / (0.28 - 0.02) = $39.76 / 0.26 = $152.92. Since the market price is lower than the present value, the stock is considered undervalued.
Name | Price ($) | 52 wk low | 52 wk high | 52 wk low % | 52 wk high % | Market Cap ($ b) | P/E | D/E | Beta | Payout Ratio |
---|---|---|---|---|---|---|---|---|---|---|
British American Tobacco | 107.29 | 99.81 | 119.91 | 7.49% | -10.52% | 102.46 | 17.65 | 2.36 | 1.08 | 50% |
GlaxoSmithKline | 38.21 | 37.24 | 49.08 | 2.60% | -22.15% | 96.22 | 7.98 | 3.00 | 0.84 | 44% |
Unilever | 42.39 | 38.60 | 46.19 | 9.82% | -8.23% | 124.01 | 22.71 | 0.64 | 0.81 | 69% |
Unilever (ADR) (NYSE: UL) is a London-headquartered consumer goods company with a large network in the Americas, Africa, Asia, Australia, Europe and the Middle East. Through its Personal Care, Foods, Refreshment, and Home Care segment, Unilever offers well-established brand names, including Axe, Dove, Lux, Rexona, and Sunsilk, Hellmann’s and Knorr, Ben & Jerry’s, Cif, Comfort, Domestos, Omo, Persil, and Surf, among others.
Strong Fundamentals: Compared to FY 2014, Unilever has reported strong FY 2015 results as follows:
- Revenues $53.27 billion, up 3.8% YoY from $51.32 billion
- Operating expenses up 3.2% YoY to $45.76 billion from $44.35 billion
- Operating Income up 7.7% YoY to $7.52 billion from $6.98 billion
- Net Income $4.91 billion, up 12.4% YoY from $4.37 billion
Dividend Growth: Since 2000, Unilever dividend growth is 16% or 1.1% annually. Currently, Unilever declares an annualized dividend of $1.32, yielding 3.02% at a payout ratio of 69%. Considering a discount rate of 25%, the present value of Unilever stock is $43.65 / (0.25 - 0.01) = $43.65 / 0.24 = $180.21. Given that the market price is lower than the present value, the stock is viewed as undervalued.
Stock name | ISIN | Last trade | P/E | EPS | Dividend/Share | Ex-Date | Payout Ratio | Dividend Yield | |
---|---|---|---|---|---|---|---|---|---|
British American Tobacco | US1104481072 | 37.99 | 0.0 | 0.0 | 2.68 | 10/3/2019 | 6.64 | ||
Glaxosmithkline | US37733W1053 | 41.03 | 18.4 | 2.2 | 1.83 | 8/8/2019 | 82 | 4.47 | |
Unilever | US9047677045 | 61.67 | 0.0 | 0.0 | 1.77 | 10/31/2019 | 2.95 |
Articles featuring British American Tobacco (BTI):
British American Tobacco PLC: 8%-Yielding Stock Raises Dividend
Wall Street Bullish on BTI Stock With a market cap of $84.9 billion, British American Tobacco PLC (NYSE: BTI) is hardly an ignored stock. On the other hand, British American Tobacco stock does get bypassed by some investors because it’s a so-called sin stock. But to each their own; everyone has to draw a line somewhere. When it comes right down to it, whether it’s overtly or covertly, there aren’t many stocks that don’t offend someone on some level. The notion of ethical investing is... Read moreDeep Dive Into The Ex-Dividend Dates For The Upcoming Week
Seeking AlphaQuick Picks & ListsDeep Dive Into The Ex-Dividend Dates For The Upcoming WeekDec. 13, 2020 2:23 PM ET|| Includes: AAP, ADT, AINV, ALLE, AMH, AMH.PD, AMH.PE, AMH.PF, AMH.PG, AMH.PH, APH, ARCC, ARES, ARES.PA, BBY, BKE, BTAFF, BTI, CCI, CIM, CIM.PA, CIM.PB, CIM.PC, CIM.PD, CPK, CWH, DIA, DJI, DLR, DLR.PC, DLR.PJ, DLR.PK, DLR.PL, DPZ, DTE, DTJ, DTP, DTW, ECL, FCAP, FPI, FPI.PB, FTV, FUND, GILD, GPN, GRMN, GWRS, HCAP, HCAPZ, HES, HI, HUN, ICE, IMBBF, IMBBY, IRM, IYY, JCI, JJSF, KAMN,... Read more4 Buffett Fat Pitch High-Yield Blue-Chip Bargains Set To Soar
Seeking AlphaDividend Ideas4 Buffett Fat Pitch High-Yield Blue-Chip Bargains Set To SoarDec. 7, 2020 4:26 PM ET|| Includes: ABBV, BTI, EPD, MMPby: Dividend SenseiDividend Sensei The Dividend KingsMaximize your income with the world’s highest-quality dividend investments SummaryJust because the S&P 500 is 40% historically overvalued doesn't mean you can't still find plenty of Buffett style "fat pitch" high-yield blue-chip bargains.9/12 quality blue-chip BTI yields a... Read more23 International Wide Moat Dividend Growth Stocks
Seeking AlphaDividend Quick Picks23 International Wide Moat Dividend Growth StocksNov. 23, 2020 12:33 AM ET|| Includes: BAESY, BTI, DEO, KAOOY, LRLCY, MTHRF, NCLTF, NCLTY, NSRGY, NVS, PDRDY, RHHBY, SNY, TCEHY, UL, UNby: Dividend Growth Investing & RetirementDividend Growth Investing & Retirement Dividend Growth Investing, long-term horizon, Dividend InvestingDividend Growth Investing & Retirement.cls-1{fill:#024999;}SummaryAs dividend growth investors, we know that wide moat stocks make... Read moreInternational Quality Dividend Growth - 2020 Reconstitution
Seeking AlphaFinancial Advisor | Fixed IncomeInternational Quality Dividend Growth - 2020 ReconstitutionNov. 22, 2020 8:58 AM ET|| Includes: BHP, BTI, DEO, EVRZF, GSK, LIN, RIOby: WisdomTreeWisdomTree Asset Management/ETF Provider, Currency, Global Equities, fixed incomeWisdom Tree Blog.cls-1{fill:#024999;}SummaryEarlier this month, WisdomTree conducted its annual reconstitution for all developed international dividend indexes - broad dividends, high dividends and quality dividend growth.In... Read more2023 DividendYields.org - Information is provided 'as is' without any warranties.